These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31907376)

  • 1. Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.
    Shamir ER; Chen YY; Krings G
    Mod Pathol; 2020 Jun; 33(6):1078-1091. PubMed ID: 31907376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center.
    Shamir ER; Chen YY; Chu T; Pekmezci M; Rabban JT; Krings G
    Am J Surg Pathol; 2019 Mar; 43(3):399-408. PubMed ID: 30489319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
    Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
    Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy.
    Singh K; Sung CJ; Quddus MR
    Breast J; 2020 Dec; 26(12):2350-2356. PubMed ID: 33047861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.
    Kuba MG; Murray MP; Coffey K; Calle C; Morrow M; Brogi E
    Mod Pathol; 2021 Aug; 34(8):1495-1506. PubMed ID: 33824462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.
    Sakr RA; Schizas M; Carniello JV; Ng CK; Piscuoglio S; Giri D; Andrade VP; De Brot M; Lim RS; Towers R; Weigelt B; Reis-Filho JS; King TA
    Mol Oncol; 2016 Feb; 10(2):360-70. PubMed ID: 26643573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.
    Shah V; Nowinski S; Levi D; Shinomiya I; Kebaier Ep Chaabouni N; Gillett C; Grigoriadis A; Graham TA; Roylance R; Simpson MA; Pinder SE; Sawyer EJ
    Breast Cancer Res; 2017 Jan; 19(1):7. PubMed ID: 28095868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.
    Harrison BT; Nakhlis F; Dillon DA; Soong TR; Garcia EP; Schnitt SJ; King TA
    Mod Pathol; 2020 Jul; 33(7):1287-1297. PubMed ID: 31932682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.
    Chen YY; Hwang ES; Roy R; DeVries S; Anderson J; Wa C; Fitzgibbons PL; Jacobs TW; MacGrogan G; Peterse H; Vincent-Salomon A; Tokuyasu T; Schnitt SJ; Waldman FM
    Am J Surg Pathol; 2009 Nov; 33(11):1683-94. PubMed ID: 19701073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
    Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
    Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast.
    Lien HC; Chen YL; Juang YL; Jeng YM
    Breast Cancer Res Treat; 2015 Apr; 150(2):447-55. PubMed ID: 25773929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity.
    Soong TR; Dillon DA; Rice-Stitt TL; Wieczorek TJ; Baker GM; Darvishian F; Collins LC; Lester SC; Schnitt SJ; Harrison BT
    Mod Pathol; 2022 Oct; 35(10):1370-1382. PubMed ID: 35477749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multinucleation is an objective feature useful in the diagnosis of pleomorphic lobular carcinoma in situ.
    Blanco LZ; Thurow TA; Mahajan A; Susnik B; Helenowski I; Chmiel JS; Sullivan ME
    Am J Clin Pathol; 2015 Nov; 144(5):722-6. PubMed ID: 26486735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.
    De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA
    Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.
    Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP
    Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas.
    Deniziaut G; Tille JC; Bidard FC; Vacher S; Schnitzler A; Chemlali W; Trémoulet L; Fuhrmann L; Cottu P; Rouzier R; Bièche I; Vincent-Salomon A
    Oncotarget; 2016 Nov; 7(45):73337-73346. PubMed ID: 27602491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations.
    Ross JS; Wang K; Sheehan CE; Boguniewicz AB; Otto G; Downing SR; Sun J; He J; Curran JA; Ali S; Yelensky R; Lipson D; Palmer G; Miller VA; Stephens PJ
    Clin Cancer Res; 2013 May; 19(10):2668-76. PubMed ID: 23575477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline CDH1 mutations in bilateral lobular carcinoma in situ.
    Petridis C; Shinomiya I; Kohut K; Gorman P; Caneppele M; Shah V; Troy M; Pinder SE; Hanby A; Tomlinson I; Trembath RC; Roylance R; Simpson MA; Sawyer EJ
    Br J Cancer; 2014 Feb; 110(4):1053-7. PubMed ID: 24366306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive lobular neoplasia of the breast: Morphologic features, clinical presentation, and management dilemmas.
    Calle C; Kuba MG; Brogi E
    Breast J; 2020 Jun; 26(6):1148-1155. PubMed ID: 32500575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobular Carcinomas
    Lee JY; Schizas M; Geyer FC; Selenica P; Piscuoglio S; Sakr RA; Ng CKY; Carniello JVS; Towers R; Giri DD; de Andrade VP; Papanastasiou AD; Viale A; Harris RS; Solit DB; Weigelt B; Reis-Filho JS; King TA
    Clin Cancer Res; 2019 Jan; 25(2):674-686. PubMed ID: 30185420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.